An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
Michele Massimino(University of Catania), Paolo Vigneri(Humanitas University), Alice Turdo(Department of Health), Stefania Staibano(University of Naples Federico II), Miriam Gaggianesi(University of Palermo), Elena Tirrò(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Federica Martorana(University of Catania), Maria Ausiliatrice Puglisi(University of Messina), Stefania Stella(University of Catania), Andrea Russo(University of Catania), Silvia Varricchio(University of Naples Federico II), Giuseppe Broggi(University of Catania), Francesco Merolla(University of Molise), Rosario Caltabiano(University of Catania), Giorgio Stassi(University of Palermo), Silvia Rita Vitale(Policlinico Universitario di Catania), Rosa Maria Di Crescenzo(University of Naples Federico II), Sebastiano Di Bella(University of Palermo), Livia Manzella(University of Catania), C Tomarchio(University of Catania), Chiara Conti(Blueprint Medicines (United States))
Cited by 1
Related Papers
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
|Cell stem cell|2014|725
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282